New Biomarker Could Unlock First Schizophrenia Cognitive Treatment

Scientists at Northwestern University discovered a biomarker that could lead to the first effective treatment for cognitive symptoms of schizophrenia, potentially helping millions live independently.

A single injection improved brain function in early tests with no negative side effects.